Sleeve Gastrectomy: Is it a Healthy Way to Lose Weight?
"Examining the Long-Term Effects on Body Composition and Metabolism"
Bariatric surgery's effectiveness is constantly being proven through facts and observable outcomes. There remains some level of debate about whether or not “healthy weight loss” is achieved. It is critical to remember that weight loss surgery is not just about reducing the numbers on a scale, but promoting health through proper diet and exercise.
We are now aware of the myriad health advantages that can be achieved by remission or improvements in various health or disease outcomes. Consistent reporting of outcomes has improved communication [1]. This study by Schiavo et al. [3] helps us maintain continuous progress in our understanding and demonstrating the benefits of weight loss surgery.
Terms such as resting metabolic rate (RMR), fat mass (FM), and fat-free mass (FFM) are familiar to nutritionists and exercise physiologists, but are not often discussed in the bariatric surgery community. Until recently, these measurements have been used to express concerns regarding the safety of weight loss surgery, with fears that surgery could lead to a catabolic state with negative nutritional and physiological consequences [2].
How Common Is Sleeve Gastrectomy?
More than half of weight-loss surgeries performed annually in the United States are gastric sleeve procedures, according to Renew Bariatrics. The same source estimates that about 380,000 people worldwide undergo the procedure each year and reports that only 1% of people who qualify for bariatric surgery receive it. A separate analysis also describes bariatric surgery as underused, estimating that approximately 1% of qualified patients undergo surgery; the ASMBS procedure totals are estimates based on available sources including BOLD, ACS/MBSAQIP, National Inpatient Sample data, and outpatient estimates.
From Early Bariatric Surgery to the Modern Sleeve
Historical accounts report that a form of bariatric surgery was performed in Spain in the 10th century: King Sancho of Leon was said to be so obese that he could not walk, ride a horse, or pick up a sword. In 1966, University of Iowa surgeon Dr. Mason proposed gastric bypass after observing weight loss among patients who had subtotal gastrectomy for cancer. Laparoscopic sleeve gastrectomy emerged later from the duodenal switch, which itself developed from the standard biliopancreatic diversion. A 2025 historical review credits pioneering surgeons' vision with helping the sleeve become a leading metabolic and bariatric procedure.
What Does the Research Say About Body Composition After Sleeve Gastrectomy?
The study by Schiavo et al. [3] offers a comparison of weight-stable sleeve gastrectomy patients and healthy volunteers. After a three-year follow-up, outcomes were similar between surgical and non-surgical participants. The idea that surgically-induced weight loss is unsafe or unhealthy is challenged by solid data.
- Preoperative State: Morbidly obese patients often have elevated FM and supranormal lean body mass (increased FFM).
- Postoperative Changes: Surgically induced weight loss helps to restore a more normal body composition.
- Medium-Term Outcomes: Postoperative sleeve gastrectomy patients demonstrate body composition characteristics comparable to normal-weight individuals.
What Recent Reviews Are Examining
A 2026 review of sleeve gastrectomy's long-term effect on lipid profiles describes bariatric surgery, particularly sleeve gastrectomy, as associated in prior studies with improvements in obesity-related conditions including diabetes, hypertension, and fatty liver. A separate review of adverse events considered studies of sleeve gastrectomy, Roux-en-Y gastric bypass, and adjustable gastric banding. Recent work is also assessing durability: a 2025 single-center study set out to evaluate sleeve gastrectomy outcomes at 10 years. A 2026 comprehensive review included studies reporting outcomes at 10 years or more across five procedures, including sleeve gastrectomy and four forms of gastric bypass.
Complications and Reasons for Weight Regain
Sleeve gastrectomy can remain effective for long-term weight loss, but a 2026 report concludes that major postoperative complications can significantly harm quality of life. One complications guide reports a 0.08% mortality rate and a 2–3% major complication rate at accredited centers, and lists staple-line leaks, bleeding, new-onset GERD, and nutritional deficiencies among potential complications. Sleeve failure may have multiple contributors, including gradual sleeve dilation, hormonal adaptation, and recurrence of problematic eating behaviors. Other reported risks include internal bleeding, spleen injury, stroke, anemia, gallbladder disease, and weight gain.
Sleeve Gastrectomy Compared With Other Options
A 2012 comparison reports similar excess-weight-loss results and resolution of comorbidities for sleeve gastrectomy and gastric bypass. The available sources also describe comparison across procedures in terms of hormonal effects, risks, long-term outcomes, and metabolic effects, but the supplied summaries do not give specific comparative results on those measures. A 2026 comparison overview reports typical one-year weight-loss ranges of 10% to 30% of total body weight across the procedures it discusses, including bypass, sleeve, band, endoscopic sleeve gastroplasty, balloon, and revision. It also identifies reversibility, recovery time, and cost as comparison dimensions without giving procedure-specific figures in the supplied summary.
Future Directions: Personalizing Weight Loss Strategies
To fully understand the impact of sleeve gastrectomy, it is important to look beyond weight loss and consider body composition and metabolic rate.
Long-Term Weight and Health Outcomes
A 2026 meta-analysis was designed to aggregate a large body of data on the long-term effects of Roux-en-Y gastric bypass and sleeve gastrectomy. Its stated outcomes of interest are weight reduction and resolution of obesity-related comorbidities. The supplied summary describes the review's purpose but does not provide pooled results, so it does not establish a specific long-term effect size for either procedure.
Research Trends and Future Directions
A bibliometric study published in 2021 examined two decades of research activity on sleeve gastrectomy, aiming to identify research hotspots and emerging trends. Its abstract notes that the procedure had become significantly more common in recent years. A 2025 overview describes sleeve gastrectomy as having evolved from gastroplasty and anti-reflux procedures into one of the most commonly performed primary metabolic surgeries in the United States and worldwide. The supplied summaries do not identify particular future technologies or research priorities.
Sleeve Gastrectomy and Metabolic Syndrome
Metabolic syndrome is described as a global health challenge involving cardiometabolic risk factors such as central obesity, elevated blood pressure, dyslipidemia, and high fasting glucose. The source notes that the increasing prevalence of metabolic syndrome remains a concern despite lifestyle interventions and medications. It presents sleeve gastrectomy as a promising intervention, but the supplied abstract does not report specific treatment outcomes or quantify its impact.
Long-Term Patient Evidence
A systematic search for studies reporting at least 10 years of laparoscopic sleeve gastrectomy results identified 11 eligible studies involving 1,020 patients. The review describes laparoscopic sleeve gastrectomy as the most commonly performed bariatric procedure worldwide. A separate 2026 study set out to compare the real-world effectiveness of semaglutide and tirzepatide with sleeve gastrectomy and gastric bypass among adults with a BMI of at least 35 treated at two urban health centers. The supplied summary states the study's design and population but does not provide comparative results.
Future studies that address dietary composition and exercise habits will enhance understanding of how these positive outcomes can be achieved consistently. The limitations of this study, acknowledged by the authors, highlight the need for broader data collection across diverse surgical populations.
The challenge now lies in incorporating bioelectric impedance analysis and RMR measurements into standard patient assessments. Gathering more data will help address questions related to different age groups, diverse outcomes, and varying degrees of obesity. As technology advances and more data become available, variability in body composition measurements will likely decrease, leading to more tailored and effective weight loss strategies.